Strs Ohio Immunity Bio, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$2.68 - $6.14 $13,132 - $30,086	-4,900 Reduced 31.61%	10,600 $39,000
Q2 2021 Jul 26, 2021	BUY	$13.41 - $22.4 $105,939 - $176,960	7,900 Added 103.95%	15,500 $221,000
Q1 2021 Apr 23, 2021	BUY	$12.83 - $42.25 $97,508 - $321,100	7,600 New	7,600 $180,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.